Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study.

Saved in:
Bibliographic Details
Title: Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study.
Authors: Taïeb, D.1 david.taieb@ap-hm.fr, Sebag, F.2, Cherenko, M.2, Baumstarck-Barrau, K.3, Fortanier, C.3, Farman-Ara, B.1, De Micco, C.4, Vaillant, J.5, Thomas, S.6, Conte-Devolx, B.7, Loundou, A.3, Auquier, P.3, Henry, J. F.2, Mundler, O.1
Source: Clinical Endocrinology. Jul2009, Vol. 71 Issue 1, p115-123. 9p. 5 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:03000664
DOI:10.1111/j.1365-2265.2008.03424.x